Colonoscopy outcomes after positive multi-target stool DNA testing in patients with and without a prior normal colonoscopy: Data from the New Hampshire Colonoscopy Registry

BACKGROUND AND AIMS: Patients who previously had a normal colonoscopy may subsequently undergo colorectal cancer (CRC) screening with multitarget stool DNA (mt-sDNA) testing. The yield of advanced neoplasia following a positive mt-sDNA test in this subgroup is not well defined. We compared colonoscopy outcomes after positive mt-sDNA tests in patients with and without a prior normal colonoscopy. METHODS: We conducted a registry-based analysis using data from the population-based New Hampshire Colonoscopy Registry (NHCR). The primary outcome was an ordered four-level categorical variable reflecting colonoscopy findings: CRC, advanced colorectal neoplasia, non-advanced colorectal neoplasia, and no neoplasia. Ordinal logistic regression models were used to evaluate the association between prior normal colonoscopy and severity of findings. RESULTS: Patients with a prior normal colonoscopy (n=739) were approximately half as likely to have more advanced findings compared with patients without a prior colonoscopy (n=994); prior normal colonoscopy was associated with lower odds of more advanced versus less advanced outcomes (OR 0.51; 95% CI 0.41-0.62; P < 0.001). However, the absolute prevalence of advanced colorectal neoplasia among patients with a previous colonoscopy remained substantial (19.1%; 95% CI 16.3-22.1%). CONCLUSIONS: Although prior normal colonoscopy is associated with lower odds of advanced findings after a positive mt-sDNA test, the residual prevalence of advanced neoplasia remains clinically meaningful. Regardless of prior screening history, there is a high yield of neoplasia, which could be attributed in part due to missed lesions on the prior colonoscopy. Our data provide potential benchmarks for expected lesion yield in this population.

Authors

Institutions

Publication Details

Journal
Clinical and Translational Gastroenterology
Published
2026-11-13
DOI
https://doi.org/10.14309/ctg.0000000000001127
Primary Topic
Colorectal Cancer Screening and Detection
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Colonoscopy outcomes after positive multi-target stool DNA testing in patients with and without a prior normal colonoscopy: Data from the New Hampshire Colonoscopy Registry

William Hisey, Joseph Carl Anderson, Lynn F. Butterly, Paul J. Limburg et al.
2 links
Clinical and Translational Gastroenterology
Colorectal Cancer Screening and Detection
article

Colonoscopy outcomes after positive multi-target stool DNA testing in patients with and without a prior normal colonoscopy: Data from the New Hampshire Colonoscopy Registry

William Hisey, Joseph Carl Anderson, Lynn F. Butterly, Paul J. Limburg, Mallik Greene, Christina M. Robinson
article en

Abstract

BACKGROUND AND AIMS: Patients who previously had a normal colonoscopy may subsequently undergo colorectal cancer (CRC) screening with multitarget stool DNA (mt-sDNA) testing. The yield of advanced neoplasia following a positive mt-sDNA test in this subgroup is not well defined. We compared colonoscopy outcomes after positive mt-sDNA tests in patients with and without a prior normal colonoscopy. METHODS: We conducted a registry-based analysis using data from the population-based New Hampshire Colonoscopy Registry (NHCR). The primary outcome was an ordered four-level categorical variable reflecting colonoscopy findings: CRC, advanced colorectal neoplasia, non-advanced colorectal neoplasia, and no neoplasia. Ordinal logistic regression models were used to evaluate the association between prior normal colonoscopy and severity of findings. RESULTS: Patients with a prior normal colonoscopy (n=739) were approximately half as likely to have more advanced findings compared with patients without a prior colonoscopy (n=994); prior normal colonoscopy was associated with lower odds of more advanced versus less advanced outcomes (OR 0.51; 95% CI 0.41-0.62; P < 0.001). However, the absolute prevalence of advanced colorectal neoplasia among patients with a previous colonoscopy remained substantial (19.1%; 95% CI 16.3-22.1%). CONCLUSIONS: Although prior normal colonoscopy is associated with lower odds of advanced findings after a positive mt-sDNA test, the residual prevalence of advanced neoplasia remains clinically meaningful. Regardless of prior screening history, there is a high yield of neoplasia, which could be attributed in part due to missed lesions on the prior colonoscopy. Our data provide potential benchmarks for expected lesion yield in this population.

Clinical and Translational Gastroenterology
Dartmouth College (US), Dartmouth–Hitchcock Medical Center (US), Exact Sciences (United States) (US), White River Junction VA Medical Center (US)
Good health and well-being
Colorectal Cancer Screening and Detection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon